Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.
about
Cell-free circulating tumor DNA in cancer"Liquid biopsy"-ctDNA detection with great potential and challengesNovel RNA markers in prostate cancer: functional considerations and clinical translationBlood-based Tumor Markers in Lung CancerBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNANormal and Cancerous Tissues Release extrachromosomal circular DNA (eccDNA) into the Circulation.Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategiesGenetic profiling of putative breast cancer stem cells from malignant pleural effusions.Serologic autoimmunologic parameters in women with primary ovarian insufficiencyAn ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.Circulating Tumor DNA as Biomarkers for Cancer Detection.Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings.The feasibility of using mutation detection in ctDNA to assess tumor dynamics.Assessment of circulating copy number variant detection for cancer screening.Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cellsLiquid biopsy: monitoring cancer-genetics in the blood.Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencingMultifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancerA comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.The dynamic range of circulating tumor DNA in metastatic breast cancerChanges in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerMyogenic transcription factors regulate pro-metastatic miR-182.Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug AdministrationChromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.The In Vitro Stability of Circulating Tumour DNA.Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.Emerging concepts in liquid biopsiesTesting for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Circulating tumor cells and DNA as liquid biopsies.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsiesCirculating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.Drug discovery in advanced prostate cancer: translating biology into therapy.Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.
P2860
Q26750899-71D6009E-CDC0-4034-B667-53FF5CF1EC11Q26779222-0579DF2F-D4A5-44C8-B6B1-13510084AD1BQ27021174-F97F8458-260D-4690-8BB6-8C388E1A5DE0Q28072736-F92B7976-F522-4C6F-9DED-CA34EF3CA11EQ28239638-079CF150-A706-4109-B774-1B52C4019E38Q30252331-DB007898-19F5-4A6F-9B68-05919D0268BAQ33275985-E0C1B217-A8C1-40B4-B50F-17895B0AAD52Q33579350-774338C0-4D7D-4132-B239-812BAD538821Q33590814-39EA2822-7681-432E-B4E7-EF694851BBE6Q33590850-D95E3FD3-006A-4D0D-8717-A9BC7B900035Q33632125-7EF6D235-0491-49CC-BD69-5162728CFCF1Q33683844-A657D404-C0A6-47EA-8D0C-E592BC6682C5Q33697983-1D3B8AE2-A968-45E7-A613-F2AA93C3B324Q33884196-484291AA-C967-4090-A97A-CC3B1FCA3BDAQ33911932-CC265A30-A10D-4CC5-835F-4A202CDE756DQ33988851-ECE7CCCB-5522-4F99-B941-6B01989D977DQ34356149-D37090E0-0956-4F6E-BBA0-45BFF3F2275FQ34382581-D2CFFD36-1F08-4B90-91F2-5EF385643518Q34500359-7D787C50-4DFE-4DE0-AD32-0FF9DAB1ABC9Q34501955-B6119780-3DAC-4856-9CD2-740AFEB85CADQ35000808-31C00034-E0A1-465C-855E-AF49395A776AQ35133788-EAB120EE-AD3D-49A4-A83A-6FE0CAFC0327Q35212779-FB0A6591-FA77-4875-8A2B-6127A34186D1Q35615320-8DEAC522-1371-4433-9377-093EFE69BBC3Q35913399-3E1C5805-AC08-4C76-8961-45DD64653FC0Q36073981-5F6475A2-90F0-41BA-B0F0-145E4BB68ACBQ36087929-C98729B8-141D-4B55-A610-0E67550D7155Q36193912-87DE4509-5AFF-4096-B527-2DDF2AB18A71Q36222235-570EC6AB-A647-4E46-9922-3B2F2E110E92Q36238197-C8F7FFFF-88AE-4BB4-A78C-FEC9707DB25CQ36337259-39C4CE05-D180-4C4B-B6B5-9CA903760100Q37242412-06AE9099-BA3E-4F33-85EC-DB66CA237E8CQ38133673-E797DBD7-2ECC-4E8D-A56F-CF9DA9EC7A8DQ38152782-40484F7B-D2CC-48BA-A79D-F1B57A7EF546Q38261856-E8F9E653-B568-461C-B650-8AF678FEC5A8Q38305991-46D6AD9A-5D24-4363-A706-9F38F9904068Q38700222-6467F85E-8410-4515-A412-3684E1201B85Q38793093-EB449DFF-D1D4-4FA7-8141-E3EB94582B04Q38839110-24080976-7A2E-49DB-9C10-FDAD06B7D7A7Q39003554-C882980A-9284-4CA3-9171-28968C8CDCB5
P2860
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor-associated copy number c ...... rough whole-genome sequencing.
@en
type
label
Tumor-associated copy number c ...... rough whole-genome sequencing.
@en
prefLabel
Tumor-associated copy number c ...... rough whole-genome sequencing.
@en
P2093
P2860
P50
P356
P1433
P1476
Tumor-associated copy number c ...... hrough whole-genome sequencing
@en
P2093
Carina Pischler
Florian Eisner
Franz Quehenberger
Hellmut Samonigg
Herbert Augustin
Jelena Belic
Jochen B Geigl
Katja Fischereder
Klaus Pantel
Martin Haeusler
P2860
P2888
P356
10.1186/GM434
P577
2013-04-05T00:00:00Z
P5875
P6179
1025230602